What are the clinical features of thyroxine (T4) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Thyroxine Overdose Features

Thyroxine overdose manifests as exogenous thyrotoxicosis with symptoms primarily driven by increased adrenergic stimulation, affecting multiple organ systems, with cardiovascular complications representing the most life-threatening manifestations. 1

Clinical Presentation

The clinical features of thyroxine overdose mirror those of thyrotoxicosis but vary significantly in timing and severity depending on the dose ingested.

Timing of Symptom Onset

A critical pitfall in managing thyroxine overdose is the delayed onset of symptoms. Patients may appear well initially and deteriorate days after ingestion due to peripheral conversion of T4 to the active T3 form 1, 2. In one severe case, a patient remained well for two days post-ingestion before mental state deterioration began on day 3 2. Symptoms may not appear until several days after ingestion 1.

Cardiovascular Features (Most Critical)

The most profound and life-threatening effects occur in the cardiovascular system 3:

  • Tachycardia (most common - 38.9% of cases) 4
  • Palpitations
  • Arrhythmias, particularly atrial fibrillation (5.3% in overdose cases) 4
  • Increased pulse and blood pressure
  • Heart failure
  • Angina
  • Myocardial infarction
  • Cardiac arrest 1
  • Cardiovascular collapse and death (rare but reported) 3, 1

Neuropsychiatric Features

  • Confusion and disorientation (23.2% of cases) 1, 4
  • Agitation and combativeness 2, 5
  • Anxiety, nervousness, irritability
  • Hyperactivity and emotional lability
  • Insomnia
  • Prolonged coma (in massive overdoses, lasting up to 2 weeks) 2
  • Delirium 2
  • Seizures (rare but reported, including in children) 1
  • Cerebral embolism 1

Metabolic and General Features

  • Fever (18.9% of cases) - temperature >38°C suggests thyroid storm 4, 2
  • Heat intolerance and excessive sweating/diaphoresis 1, 5
  • Significant weight loss (one patient lost 20 kg over 15 days) 5
  • Increased appetite
  • Fatigue

Musculoskeletal Features

  • Tremors 1
  • Muscle weakness
  • Hyperreflexia 5

Gastrointestinal Features

  • Diarrhea
  • Vomiting
  • Abdominal cramps
  • Elevated liver function tests 1

Other Features

  • Dyspnea 1, 2
  • Hair loss
  • Menstrual irregularities
  • Shock and coma (severe cases) 1

Laboratory Findings

Overt thyrotoxicosis from overdose is characterized by:

  • Elevated serum free T4 and T3 (can remain elevated for 11+ days in massive overdose) 2
  • Suppressed TSH (<0.01 mU/L) 3
  • Elevated NT-proBNP (may indicate brain injury and predict recovery in coma cases) 2

Severity Stratification

Assessment of cardiovascular and neuromuscular complications is essential 3. Features suggesting thyroid storm (life-threatening emergency):

  • Fever >38°C
  • Persistent tachycardia
  • Altered mental status/coma
  • Cardiovascular instability 2

Important Clinical Nuances

Despite high ingested doses, most patients (>90%) experience minimal or no symptoms, particularly in pediatric populations 4. However, the lack of dose-dependent symptom correlation means you cannot predict severity based on ingested amount alone 6. Late-onset symptoms occur in 43% of initially asymptomatic patients 6, necessitating prolonged monitoring.

Mortality is extremely rare even with massive ingestions 4, but when severe complications occur, they require aggressive intervention including beta-blockers, corticosteroids, cholestyramine, and potentially plasmapheresis 1, 7.

The moderate correlation between hormone elevation and clinical manifestations 3 means symptoms from increased adrenergic stimulation (tachycardia, anxiety) appear more pronounced in younger patients 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.